Cytotoxicity and genotoxicity assessment of silver nanoparticles in mouse

Nanotoxicology

Volumn 8, Issue SUPPL. 1, 2014, Pages 36-45

  Li, Yan ^a   Bhalli, Javed A ^a,d   Ding, Wei ^a   Yan, Jian ^a   Pearce, Mason G ^a   Sadiq, Rakhshinda ^b   Cunningham, Candice K ^a,e   Jones, M Yvonne ^a   Monroe, William A ^a   Howard, Paul C ^a   Zhou, Tong ^c   Chen, Tao ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b NATIONAL INSTITUTE FOR BIOTECHNOLOGY AND GENETIC ENGINEERING NIBGE   (Pakistan)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d Department of Molecular and Anatomical Imaging   (United States)

^e RJ Reynolds   (United States)

Author keywords

Clastogenicity; in vivo comet assay; in vivo micronucleus assay; in vivo pig a gene mutation assay; Mutagenicity; Silver nanoparticles

Indexed keywords

POVIDONE; SILICON; SILVER NANOPARTICLE; METAL NANOPARTICLE; SILVER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE MARROW TOXICITY; CLASTOGENICITY; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; GENOTOXICITY; LIVER TOXICITY; MALE; MASS SPECTROMETRY; MICRONUCLEUS TEST; MOUSE; MUTAGENICITY; MUTATION RATE; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RETICULOCYTE COUNT; TOXICITY TESTING; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CHEMISTRY; MUTAGEN TESTING;

ANIMALS; METAL NANOPARTICLES; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MUTAGENICITY TESTS; SILVER;

EID: 84905965473     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2013.855827     Document Type: Article

References (45)

1. Agarwal A, Weis TL, Schurr MJ, Faith NG, Czuprynski CJ, McAnulty JF, et al. 2009. Surfaces modified with nanometer-thick silver-impregnated polymeric films that kill bacteria but support growth of mammalian cells. Biomaterials 31: 680-90.
2. Asare N, Instanes C, Sandberg WJ, Refsnes M, Schwarze P, Kruszewski M, Brunborg G. 2012. Cytotoxic and genotoxic effects of silver nanoparticles in testicular cells. Toxicology 291: 65-72.
3. Asharani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. 2009. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3: 279-90.
4. Asharani PV, Wu YL, Gong Z, Valiyaveettil S. 2008. Toxicity of silver nanoparticles in zebrafish models. Nanotechnology 19: 255102.
5. Asharani PV, Wu YL, Gong Z, Valiyaveettil S. 2011. Comparison of the toxicity of silver, gold and platinum nanoparticles in developing zebrafish embryos. Nanotoxicology 5: 43-54.
6. Bhalli JA, Pearce MG, Dobrovolsky VN, Heflich RH. 2011. Manifestation and persistence of Pig-a mutant red blood cells in C57BL/6 mice following single and split doses of N-ethyl-Nnitrosourea. Environ Mol Mutagen 52: 766-73.
7. Burlinson B. 2012. The in vitro and in vivo comet assays. Methods Mol Biol 817: 143-63.
8. Dertinger SD, Miura D, Hayashi M, MacGregor JT. 2011a. The in vivo cytogenetic damage. Mutagenesis 26: 139-45.
9. Dertinger SD, Phonethepswath S, Weller P, Nicolette J, Murray J, Sonders P, et al. 2011b. International Pig-a gene mutation assay trial: evaluation of transferability across 14 laboratories. Environ Mol Mutagen 52: 690-8.
10. Dertinger SD, Torous DK, Hall NE, Tometsko CR, Gasiewicz TA. 2000. Malaria-infected erythrocytes serve as biological standards to ensure reliable and consistent scoring of micronucleated erythrocytes by flow cytometry. Mutat Res 464: 195-200.
11. Dertinger SD, Torous DK, Hayashi M, MacGregor JT. 2011c. Flow cytometric scoring of micronucleated erythrocytes: an efficient platform for assessing in vivo cytogenetic damage. Mutagenesis 26: 139-45.
12. Ding W, Levy DD, Bishop ME, Lyn-Cook Lascelles E, Kulkarni R, Chang CW, et al. 2011. Methyleugenol genotoxicity in the Fischer 344 rat using the comet assay and pathway-focused gene expression profiling. Toxicol Sci 123: 103-12.
13. Dusinska M. 2000. The Comet assay, modified for detection of oxidised bases with the use of bacterial repair endonucleases. [Online] Available at: http://www.cometassayindia.org/Dusinska-protocol.PDF [Last accessed 9 August 2013].
14. Feng QL, Cui FZ, Kim TN, Kim JW. 1999. Ag-substituted hydroxyapatite coatings with both antimicrobial effects and biocompatibility. J Mater Sci Lett 18: 559-61.
15. Fernández-Urrusuno R, Fattal E, Féger J, Couvreur P, Thérond P. 1997. Evaluation of hepatic antioxidant systems after intravenous administration of polymeric nanoparticles. Biomaterials 18: 511-17.
16. Foldbjerg R, Dang DA, Autrup H. 2011. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol 85: 743-50.
17. Genter MB, Newman NC, Shertzer HG, Ali SF, Bolon B. 2012. Distribution and systemic effects of intranasally administered 25 nm silver nanoparticles in adult mice. Toxicol Pathol 40: 1004-13.
18. Gonzalez L, Lison D, Kirsch-Volders M. 2008. Genotoxicity of engineered nanomaterials: a critical review. Nanotoxicology 2: 252-73.
19. Hagens WI, Oomen AG, de Jong WH, Cassee FR, Sips AJAM. 2007. What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul Toxicol Pharmacol 49: 217-29.
20. ICTA. 2006. Petition requesting FDA amend its regulations for products composed of engineered nanoparticles generally and sunscreen drug products composed of engineered nanoparticles specifically. [Online] Available at: http://www.icta.org/doc/Nano%20FDA%20petition% 20final.pdf [Last accessed 9 August 2013].
21. ICTA. 2008. Groups demand EPA stop sale of 200+ potentially dangerous nano-silver products. [Online] Available at: http://www. icta.org/files/2011/12/ CTA-nano-silver-press-release-5-1-08.pdf [Last accessed 9 August 2013].
22. JaCVAM. 2009. International validation of the in vivo rodent alkaline comet assay for the detection of genotoxic carcinogens. [Online] Available at: http://cometassay.com/JaCVAM.pdf [Last accessed 9 August 2013].
23. Ji JH, Jung JH, Kim SS, Yoon JU, Park JD, Choi BS, et al. 2007. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 19: 857-71.
24. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, et al. 2008. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 20: 575-83.
25. Kim HR, Kim MJ, Lee SY, Oh SM, Chung KH. 2011a. Genotoxic effects of silver nanoparticles stimulated by oxidative stress in human normal bronchial epithelial (BEAS-2B) cells. Mutat Res 726: 129-35.
26. Kim JS, Sung JH, Ji JH, Song KS, Lee JH, Kang CS, Yu IJ. 2011b. In vivo genotoxicity of silver nanoparticles after 90-day silver nanoparticle inhalation exposure. Saf Health Work 2: 34-8.
27. Klien K, Godnic-Cvar J. 2012. Genotoxicity of metal nanoparticles: focus on in vivo studies. Arh Hig Rada Toksikol 63: 133-45.
28. Kux L. 2012. FDA response to 2006-P-0213-citizen petition. [Online] Available at: http://www.icta.org/doc/Andrew%20 Kimbrell-FDA-2006-P-0213- Citizen%20Petition.pdf [Last accessed 9 August 2013]
29. Landsiedel R, Kapp MD, Schulz M, Wiench K, Oesch F. 2009. Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations- many questions, some answers. Mutat Res 681: 241-58.
30. Li M, Reineke J. 2012. Physiologically based pharmacokinetic modeling for nanoparticle toxicity study. Methods Mol Biol 926: 369-382.
31. Li Y, Chen DH, Yan J, Chen Y, Mittelstaedt RA, Zhang Y, et al. 2012a. Genotoxicity of silver nanoparticles evaluated using the Ames test and in vitro micronucleus assay. Mutat Res 745: 4-10.
32. Li Y, Yan J, Bhalli J, Sadiq R, Ding W, Chen T. 2012b. Micronuclei in TK6 cells are increased by silver nanoparticles in a dose, size and surface coating-dependent manner. Toxicologist 100: 140.
33. Loeschner K, Hadrup N, Qvortrup K, Larsen A, Gao X, Vogel U, et al. 2011. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol 8: 18.
34. Madhumathi K, Sudheesh Kumar PT, Abhilash S, Sreeja V, Tamura H, Manzoor K, et al. 2009. Development of novel chitin/nanosilver composite scaffolds for wound dressing applications. J Mater Sci Mater Med 21: 807-13.
35. Mei N, Zhang Y, Chen Y, Guo X, Ding W, Ali SF, et al. 2012. Silver nanoparticle-induced mutations and oxidative stress in mouse lymphoma cells. Environ Mol Mutagen 53: 409-19.
36. Monfardini C, Veronese FM. 1998. Stabilization of substances in circulation. Bioconjug Chem 9: 418-50.
37. OECD. 1997. Guideline for the testing of chemicals, guideline 474 mammalian erythrocyte micronucleus test. [Online] Available at: http://www.oecd.org/chemicalsafety/assessmentofchemicals/1948442.pdf [Last accessed 9 August 2013].
38. Oesch F, Landsiedel R. 2012. Genotoxicity investigations on nanomaterials. Arch Toxicol 86: 985-94.
39. Ordzhonikidze CG, Ramaiyya LK, Egorova EM, Rubanovich AV. 2009. Genotoxic effects of silver nanoparticles on mice in vivo. Acta Naturae 1: 99-101.
40. Petersen EJ, Nelson BC. 2010. Mechanisms and measurements of nanomaterial-induced oxidative damage to DNA. Anal Bioanal Chem 398: 613-50.
41. Phonethepswath S, Franklin D, Torous DK, Bryce SM, Bemis JC, Raja S, et al. 2010. Pig-a mutation: kinetics in rat erythrocytes following exposure to five prototypical mutagens. Toxicol Sci 114: 59-70.
42. Singh N, Aardema M, Henderson L, Muller L. 2009a. Evaluation of the ability of a battery of engineered nanomaterials. Mutat Res 30: 1-256.
43. Singh N, Manshian B, Jenkins GJ, Griffiths SM, Williams PM, Maffeis TG, et al. 2009b. NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials 30: 3891-914.
44. Tometsko AM, Dertinger SD, Torous DK. 1993. Analysis of micronucleated cells by flow cytometry. 2. Evaluating the accuracy of high-speed scoring. Mutat Res 292: 137-43.
45. Woodrow Wilson International Center. 2011. A nanotechnology consumer products inventory. [Online] Available at: http://www. nanotechproject.org/ inventories/consumer/analysis-draft/. Accessed on 9 August 2013.